Article Text

Download PDFPDF
CASE REPORT
Multiple primary malignancies of laryngeal cancer, small cell lung cancer and squamous cell lung cancer in a patient: how to approach MPMs
  1. Eun Kyoung Kim1,
  2. Joo-Yeon Kim2,
  3. Bo Mi Kim2,
  4. Sung-Nam Lim3
  1. 1H Plus Yangji Hospital, Seoul, Republic of Korea
  2. 2Department of Pathology, Inje University Haeundae Paik Hospital, Busan, Republic of Korea
  3. 3Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, Republic of Korea
  1. Correspondence to Professor Sung-Nam Lim, sungnaml{at}gmail.com

Summary

Lung malignancies presenting in association with head and neck cancers are well documented, while laryngeal cancers presenting with simultaneous small cell lung cancer and squamous cell lung cancer have been rarely reported. We report a case of a man aged 65 years with a triple primary malignancy of the lung and larynx. Without a meticulous approach, the patients may not receive curative aim treatment due to incomplete staging. The patient underwent concurrent chemoradiotherapy for locally advanced laryngeal cancer, small cell lung cancer and squamous cell lung cancer followed by combination chemotherapy with etoposide and cisplatin for synchronous double primary lung cancer. Following this therapy, he achieved a complete response of larynx cancer, but a partial response of small cell lung cancer and a stable disease of squamous cell lung cancer. A meticulous diagnostic approach should be encouraged to pursue the possibility of curative treatment and achieve better outcomes for such patients.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors EKK planned and wrote the manuscript. BMK and J-YK reviewed and described the pathological results of this manuscript. SNL approved and supervised final manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.